Biobanking and Biomolecular Research Infrastructure (BBMRI-ERIC)
14 October 2021
Modified: 15 September 2022
Reading time: 2 minute(s)
BBMRI-ERIC aims to promote the development of new, effective therapeutic treatments by aligning the needs and opportunities of researchers, the industry and patients in need of treatment through related biomedical research. As part of this, the organisation provides high-quality management services, advice on ethical, legal and social issues, and IT support to participants in research programmes. The coordinator of the BBMRI node in Hungary is Semmelweis University, and the University of Szeged, the University of Pécs and the Central Hospital of Southern Pest are among its participants.
|Name||Biobanking and Biomolecular Research Infrastructure - European Research Infrastructure Consortium|
|Year of foundation||2014|
|Number of member countries||17|
|Participating countries||Members: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, Germany, Greece, Hungary, Italy, Latvia, Malta, the Netherlands, Poland, Portugal, Norway, Slovenia, Sweden, United Kingdom,
observer: Cyprus, Lithuania, Spain, Switzerland, Turkey, International Agency For Research On Cancer WHO
|Partner institutions in Hungary in 2021||
University of Pécs,
University of Szeged,
Central Hospital of Southern Pest,
Richter Gedeon Zrt.
|Public administration representative||
Attila Levente Szőcs
National Research, Development and Innovation Office
Department for International Affairs
1077 Budapest, Kéthly Anna tér 1.
Phone: +36 1 896 1566
Mária Judit Molnár
Professor, Head of the Institute of Genomic Medicine and Rare Diseases, Faculty of Medicine, Semmelweis University
|Membership payments||2021: EUR 21 496 (≈ HUF 7,7 million)
2022: EUR 40 901 (≈ HUF 16 million)
Benefits of the membership for Hungary
- It unifies the activities of the individual biobanks, creating a huge database for research.
- Optimising diagnostic and therapeutic improvements, patient-centred care.
- Support for biomedical, biological research.
- The biobank research infrastructure is generating a national data asset that will form the basis for the development of many services in the future.
- It catalyses domestic innovation, both in the pharmaceutical industry and in translational research, diagnostic services and health coaching.
Updated: 15 September 2022